The PhD Presentation

Presentation

The Research Doctorate in the Area of ​​Drugs and Innovative Treatments is an interdisciplinary doctorate characterized by the central theme: "Improvement of human health through the identification of new active ingredients, both synthetic and coming from the natural world, and new therapeutic treatment strategies". This theme aggregates different methodologies of the ERC-European Research Council (PE - Physical and Mathematical Sciences, LS - Life Sciences, and one concerning epilepsy genomics with a bioinformatic approach based on the use of "Big Data"). Some of the topics studied in recent years, perfectly in line with those identified by the PNRR (Italian National Recovery and Resilience Plan), relate to Neuroscience and Neuropharmacology, Models of sustainable nutrition, Diagnosis - Innovative Therapies in Precision Medicine, Emerging Infectious Diseases, Consequences and Challenges of Aging, Development of "Human-based" Preclinical Models.  A network of scientific relationships with leading international universities allows to offer cultural exchanges for the training of learners.

The doctorate is organized in two curricula "Pharmaceutical and Nutraceutical Sciences" and "Pharmacology, Toxicology and Innovative Treatments". Involves the CUN Reference Areas related to the Drug Area (CUN Areas 05, 03, 06) and the following disciplinary scientific areas:

 

BIO/14 – PHARMACOLOGY

BIO/15 – PHARMACEUTICAL BIOLOGY

CHIM/08 – MEDICINAL CHEMISTRY

CHIM/09 – PHARMACEUTICAL AND TECHNOLOGICAL APPLICATIONS OF CHEMISTRY

CHIM/10 – FOOD CHEMISTRY

CHIM/01 – ANALYTICAL CHEMISTR

MED/26 – NEUROLOGY

MED/38 – GENERAL AND SPECIALIST PEDIATRICS

MED/39 – CHILDHOOD NEUROPSYCHIATRY

MED/06 – MEDICAL ONCOLOGY

 

Curriculum in Pharmaceutical and Nutraceutical Sciences

The curriculum in Pharmaceutical Sciences is set up on an educational-scientific offer aimed at training experts and scholars in the sector by providing them with the multiple skills that must characterize highly specialized operators in the field, destined to be inserted in the research laboratories of the pharmaceutical industries, of academic institutes. and research institutions, in the field of design and synthesis of new drugs, the optimization of their formulation and purification of natural compounds, their characterization and quality control of both synthetic and natural molecules, both in the finished product and in biological media as well as in the study of bioactive metabolites from food and medicinal plants. It can be assumed that graduates in Pharmaceutical Chemistry and Technology, Pharmacy, Biotechnology and Chemistry are particularly interested in this curriculum.

 

Specificity: Design, synthesis and molecular modeling of drugs, Natural substances of plant origin, Innovative pharmaceutical technologies for the optimization of drugs, Advanced methodologies in pharmaceutical analysis.

 

Curriculum in Pharmacology, Toxicology and Innovative Treatments

The Curriculum Pharmacology is focused on provide PhD students with the cultural background and methodological preparation necessary to successfully carry out preclinical and clinical, academic or industrial research activities, in the field of Pharmacology, Pharmacognosy and Toxicology. The specific training objective it to train high level researchers skilled to face the challenge of individuating, studying and applying innovative treatments. Natural substances and products, small synthetic molecules, biotech drugs and cell therapy are investigated.  Advanced technologies are available to PhD students for the study of new therapeutic targets and for the evaluation of the effectiveness and safety of new products. It can be assumed that graduates in Pharmacy, Pharmaceutical Chemistry and Technology, Biotechnology and Medicine are particularly interested in this curriculum.

 

Specificity: Pharmacology and toxicology of the cardiovascular system, Pharmacology and toxicology of the nervous system, Pharmacology and toxicology of hormones and autacoids, Pharmacology and toxicology of inflammation and cell proliferation, Anticancer pharmacology